Speaker Details

Brittany L Dulmage, MD, FAAD

Brittany L Dulmage, MD, FAAD

SESSIONS

F070 The Morbilliform Eruption: Differentiation and Treatment of Viral, Low-risk Drug, Severe Cutaneous Adverse Reactions, and GVHD
Mar 9, 2025 • 3:30 PM - 5:30 PM • W204C

HANDOUTS

Login to view handouts

DISCLOSURES

Azitra, Inc – Investigator(Grants/Research Funding); Hoth Therapeutics – Data Safety Monitoring Board(Honoraria); Novocure – Consultant (1099 relationship)(Honoraria); Xencor – Consultant (1099 relationship)(Fees);